68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle
Abstract Background The aim of this study was to prospectively compare the detection rate of 68Ga-PSMA versus 11C-Choline in men with prostate cancer with biochemical recurrence and to demonstrate the added value of a tri-modality PET/CT-MRI system. Methods We analysed 36 patients who underwent both...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-05-01
|
Series: | European Journal of Hybrid Imaging |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41824-018-0027-1 |
id |
doaj-b1a487aca3df432ca46f38b41a168c80 |
---|---|
record_format |
Article |
spelling |
doaj-b1a487aca3df432ca46f38b41a168c802020-11-25T01:30:13ZengSpringerOpenEuropean Journal of Hybrid Imaging2510-36362018-05-012111610.1186/s41824-018-0027-168Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttleOmar Alonso0Gerardo dos Santos1Margarita García Fontes2Henia Balter3Henry Engler4Uruguayan Centre of Molecular Imaging (CUDIM)Uruguayan Centre of Molecular Imaging (CUDIM)Uruguayan Centre of Molecular Imaging (CUDIM)Uruguayan Centre of Molecular Imaging (CUDIM)Uruguayan Centre of Molecular Imaging (CUDIM)Abstract Background The aim of this study was to prospectively compare the detection rate of 68Ga-PSMA versus 11C-Choline in men with prostate cancer with biochemical recurrence and to demonstrate the added value of a tri-modality PET/CT-MRI system. Methods We analysed 36 patients who underwent both 11C-Choline PET/CT and 68Ga-PSMA PET/CT scanning within a time window of 1-2 weeks. Additionally, for the 68Ga-PSMA scan, we used a PET/CT-MRI (3.0 T) system with a dedicated shuttle, acquiring MRI images of the pelvis. Results Both scans were positive in 18 patients (50%) and negative in 8 patients (22%). Nine patients were positive with 68Ga-PSMA alone (25%) and one with 11C-Choline only (3%). The median detected lesion per patient was 2 for 68Ga-PSMA (range 0-93) and 1 for 11C-Choline (range 0-57). Tumour to background ratios in all concordant lesions (n = 96) were higher for 68Ga-PSMA than for 11C-Choline (110.3 ± 107.8 and 27.5 ± 17.1, mean ± S.D., for each tracer, respectively P = 0.0001). The number of detected lesions per patient was higher for 11C-Choline in those with PSA ≥ 3.3 ng/mL, while the number of detected lesions was independent of PSA levels for 68Ga-PSMA using the same PSA cut-off value. Metastatic pelvic lesions were found in 25 patients (69%) with 68Ga-PSMA PET/CT, in 18 (50%) with 11C-Choline PET/CT and in 21 (58%) with MRI (3.0 T). MRI was very useful in detecting recurrence in cases classified as indeterminate by means of PET/CT alone at prostate bed. Conclusions In patients with prostate cancer with biochemical recurrence 68Ga-PSMA detected more lesions per patient than 11C-Choline, regardless of PSA levels. PET/CT-MRI (3.0 T) system is a feasible imaging modality that potentially adds useful relevant information with increased accuracy of diagnosis.http://link.springer.com/article/10.1186/s41824-018-0027-1Prostate cancerBiochemical recurrence11C-Choline68Ga-PSMAPET/CTPET/MRI |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Omar Alonso Gerardo dos Santos Margarita García Fontes Henia Balter Henry Engler |
spellingShingle |
Omar Alonso Gerardo dos Santos Margarita García Fontes Henia Balter Henry Engler 68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle European Journal of Hybrid Imaging Prostate cancer Biochemical recurrence 11C-Choline 68Ga-PSMA PET/CT PET/MRI |
author_facet |
Omar Alonso Gerardo dos Santos Margarita García Fontes Henia Balter Henry Engler |
author_sort |
Omar Alonso |
title |
68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle |
title_short |
68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle |
title_full |
68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle |
title_fullStr |
68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle |
title_full_unstemmed |
68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle |
title_sort |
68ga-psma and 11c-choline comparison using a tri-modality pet/ct-mri (3.0 t) system with a dedicated shuttle |
publisher |
SpringerOpen |
series |
European Journal of Hybrid Imaging |
issn |
2510-3636 |
publishDate |
2018-05-01 |
description |
Abstract Background The aim of this study was to prospectively compare the detection rate of 68Ga-PSMA versus 11C-Choline in men with prostate cancer with biochemical recurrence and to demonstrate the added value of a tri-modality PET/CT-MRI system. Methods We analysed 36 patients who underwent both 11C-Choline PET/CT and 68Ga-PSMA PET/CT scanning within a time window of 1-2 weeks. Additionally, for the 68Ga-PSMA scan, we used a PET/CT-MRI (3.0 T) system with a dedicated shuttle, acquiring MRI images of the pelvis. Results Both scans were positive in 18 patients (50%) and negative in 8 patients (22%). Nine patients were positive with 68Ga-PSMA alone (25%) and one with 11C-Choline only (3%). The median detected lesion per patient was 2 for 68Ga-PSMA (range 0-93) and 1 for 11C-Choline (range 0-57). Tumour to background ratios in all concordant lesions (n = 96) were higher for 68Ga-PSMA than for 11C-Choline (110.3 ± 107.8 and 27.5 ± 17.1, mean ± S.D., for each tracer, respectively P = 0.0001). The number of detected lesions per patient was higher for 11C-Choline in those with PSA ≥ 3.3 ng/mL, while the number of detected lesions was independent of PSA levels for 68Ga-PSMA using the same PSA cut-off value. Metastatic pelvic lesions were found in 25 patients (69%) with 68Ga-PSMA PET/CT, in 18 (50%) with 11C-Choline PET/CT and in 21 (58%) with MRI (3.0 T). MRI was very useful in detecting recurrence in cases classified as indeterminate by means of PET/CT alone at prostate bed. Conclusions In patients with prostate cancer with biochemical recurrence 68Ga-PSMA detected more lesions per patient than 11C-Choline, regardless of PSA levels. PET/CT-MRI (3.0 T) system is a feasible imaging modality that potentially adds useful relevant information with increased accuracy of diagnosis. |
topic |
Prostate cancer Biochemical recurrence 11C-Choline 68Ga-PSMA PET/CT PET/MRI |
url |
http://link.springer.com/article/10.1186/s41824-018-0027-1 |
work_keys_str_mv |
AT omaralonso 68gapsmaand11ccholinecomparisonusingatrimodalitypetctmri30tsystemwithadedicatedshuttle AT gerardodossantos 68gapsmaand11ccholinecomparisonusingatrimodalitypetctmri30tsystemwithadedicatedshuttle AT margaritagarciafontes 68gapsmaand11ccholinecomparisonusingatrimodalitypetctmri30tsystemwithadedicatedshuttle AT heniabalter 68gapsmaand11ccholinecomparisonusingatrimodalitypetctmri30tsystemwithadedicatedshuttle AT henryengler 68gapsmaand11ccholinecomparisonusingatrimodalitypetctmri30tsystemwithadedicatedshuttle |
_version_ |
1725092804267343872 |